Recent data suggest that SARS-CoV2 infection can lead to a deterioration in glycemic control, involving both profound insulin resistance, and impaired insulin secretion, together with leading to diabetic ketoacidosis, DKA [22, 23]. The gene discussed is INS; the disease is diabetic ketoacidosis.